Catalyst
Slingshot members are tracking this event:
Crinetics (CRNX) Expecting to Initiate Phase 2 of CRN00808 For the Treatment of Acromegaly in early 2019
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CRNX | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 28, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03789656
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Crn00808, Acromegaly
